Frequently Asked Questions
The market for Devic’s Syndrome Treatment Market is expected to reach US$ 156.8 Mn by 2027.
The Devic’s Syndrome Treatment Market is expected to see significant CAGR growth over the coming years, at 12.0%.
The report is forecasted from 2019-2027.
The base year of this report is 2018.
Alexion Pharmaceuticals, Inc., Teva Pharmaceuticals, Fresenius Kabi AG, Pharmacia & Upjohn (a subsidiary of Pfizer), Mylan Pharmaceuticals, Inc., Chugai Pharmaceutical, MedImmune LLC, and RemeGen, Ltd. are some of the major players in the global market.